LEADER 01386nam  2200373Ia 450 
001 9910696902603321
005 20230902161607.0
035   $a(CKB)5470000002383871
035   $a(OCoLC)568987419
035   $a(EXLCZ)995470000002383871
100   $a20100325d2001      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $emonoclonal antibodies used as reagents in drug manufacturing
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research,$d[2001]
215   $a1 electronic resource (8 pages)
300   $a"March 2001."
320   $aIncludes bibliographical references (page 8).
517   $aGuidance for industry 
606   $aMonoclonal antibodies$xTherapeutic use$zUnited States
606   $aBiological reagents
615  0$aMonoclonal antibodies$xTherapeutic use
615  0$aBiological reagents.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696902603321
996   $aGuidance for industry$93434577
997   $aUNINA